This information was published, 2015-10-15 08:00 CEST (GLOBE NEWSWIRE) —
The Nomination Committee for Episurf Medical shall have four members. The members are selected by the three largest shareholders/owner groups in the company who are entitled to appoint one member each. In addition, the Chairman of the Board is to be appointed to the Nomination Committee.
In accordance with the above principles, the Nomination Committee consists of the following four members:
Saeid Esmaeilzadeh, Chairman of the Board of Episurf Medical AB
Ashkan Pouya, representing Serendipity Ixora AB
Peter Ragnarsson, representing LMK Stiftelsen
Björg Arnardóttir, representing Kaupthing HF.
The Nomination Committee has appointed Ashkan Pouya as its chairman.
The shareholders having appointed members of the Nomination Committee together represent approximately 41,8 per cent of the voting rights for all shares in Episurf Medical.
Shareholders may contact the Committee with proposals for Board members. Proposals must be sent to the Chairman, via firstname.lastname@example.org.
For more information please visit the company website: www.episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are in development for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system will enable implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention.
Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. The information in this press release is such that Episurf Medical AB is required to disclose in accordance with the Securities Markets Act and/or the Financial Instruments Trading Act.
For more information, please contact:
Rosemary Cunningham Thomas, CEO, Episurf Medical
Tel: +46 (0) 70-7655892
Tel: +44 (0) 7803-753603